Today, the Community Oncology Alliance (COA) continues to expose the inhumane pain, suffering, and anxiety inflicted by Pharmacy Benefit Managers (PBMs) on patients with cancer with the release of another paper documenting real-life PBM horror stories.

As we enter the election season American outrage and concern over health care costs continues to be a priority issue on voters’ minds. The byzantine and complex system we have built continues to present a formidable burden for policymakers who must face the entrenched but completely wrong policies that have been passed down from year to year.

Community Oncology Alliance Applauds Administration for Taking Bold Action to Address High Drug Prices, Cautions Against Misguided Policy Changes That Would Negatively Impact Cancer Patients

WASHINGTON — The Trump administration is proposing huge changes in the way Medicare pays doctors for the most common of all medical services, the office visit, offering physicians basically the same amount, regardless of a patient’s condition or the complexity of the services provided. Administration officials said the proposal would radically reduce paperwork burdens, freeing doctors to spend more time with patients. The government would pay one rate for new patients and another, lower rate for visits with established patients.

Community-based cancer care continues to regress, with an 11.3% increase in the number of community cancer clinic closings since 2016, according to the 2018 Community Oncology Alliance (COA) Practice Impact Report, which was released during the 2018 Community Oncology Conference.

New York Cancer & Blood Specialists has been nominated as one of the best Oncology Practices in the Queens Boro.

Medicaid expansion helps big business reduce competition.

Community Oncology Alliance Files Lawsuit Against Federal Government to Stop Unconstitutional Cut to Cancer Drug Reimbursement. Application of 2% Sequester Cut to Medicare Part B Drug Reimbursement is Unconstitutional and Illegal; Costing Seniors and Taxpayers Billions

Eighty-five percent of survey respondents said Trump’s drug pricing proposal could increase prescription drug costs and negatively impact patient care access.

We at New York Cancer & Blood Specialists would like to congratulate Dennis Caruana, who will soon enroll at Yale School of Medicine to become a doctor!